Premium
Protection afforded by live attenuated SIV is associated with rapid killing kinetics of CTLs
Author(s) -
Rollman Erik,
Mason Rosemarie D.,
Lin Jie,
Brooks Andrew G.,
Kent Stephen J.
Publication year - 2008
Publication title -
journal of medical primatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.31
H-Index - 42
eISSN - 1600-0684
pISSN - 0047-2565
DOI - 10.1111/j.1600-0684.2008.00326.x
Subject(s) - ctl* , simian immunodeficiency virus , virology , immunology , attenuated vaccine , biology , cd8 , cytotoxic t cell , antigen , vaccination , degranulation , granzyme b , immune system , in vitro , virulence , biochemistry , receptor , gene
Background Live attenuated SIV vaccines are highly efficacious, but how they mediate protection is poorly understood. A feature of the effectiveness of live attenuated vaccines is their ability to control high dose challenge viruses early, without a large peak of acute viraemia. We hypothesized that long‐lived antigen exposure from live attenuated SIV may result in CD8+ cytotoxic T lymphocytes persistently capable of rapidly cytolytic potential. Methods We employed a kinetic degranulation assay to study multiple tetramer+ SIV‐specific CTL specificities before and after the SIV mac251 challenge of pigtail macaques inoculated with a live attenuated SIV. Results Live attenuated SIV‐vaccinated animals rapidly controlled a subsequent challenge, with minimal viraemia after exposure. For over 9 months after the initial vaccination with live attenuated SIV we could detect both Gag‐ and Tat‐specific CTLs that maintained a long‐term capacity to rapidly degranulate (CD107a expression) and release granzyme B within 30 minutes of antigen exposure. This rapid cytolytic phenotype was maintained throughout the early period after challenge, despite the absence of a marked enhancement in CTL frequencies. Conclusions Our results suggest that highly functional CTLs may contribute to the remarkable efficacy of live attenuated SIV vaccines. Studying the killing kinetics of CTLs induced by other, safer, HIV vaccines could facilitate a better understanding of the requirements for an effective HIV vaccine.